DR. KARL-LUDWIG KLEY
Dr. Karl-Ludwig Kley is Rantum’s Industrial Partner for Healthcare & Pharma. He was previously long-term CEO of Merck, the German DAX-30 pharma company. Currently, Dr. Karl-Ludwig Kley is member of the supervisory board of Lufthansa. Previously he was Chairman of E.ON (the DAX-30 utility company) and a member of the supervisory boards of BMW and Verizon (the Fortune-100 US telecom company). He holds a Ph.D. in law from the LMU University of Munich.